港股半導體股集體走強 華虹半導體(1347.HK)漲超6%
格隆匯4月7日丨晶門半導體漲超8%,華虹半導體漲超6%,康特隆和ASM太平洋漲超5%,中芯國際和中電華大科技漲超4%。SIA公佈的數據顯示,2月份全球半導體產品的銷售額為395億美元,同比增長14.7%,高於1月份的13.2%。1月份和2月份全球半導體產品銷售額的同比增長率均超過10%,也就意味着今年前兩個月的銷售額,遠高於去年同期。SIA總裁透露,全球半導體產品的月度銷售額,同比增長可能還會保持一段時間。他此前曾表示,全球半導體產品的銷售額,在今年將開始強勁增長,產量也正在提升,以滿足增加的市場需求,緩解汽車和其他行業芯片的持續短缺。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.